Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies

Journal of Acquired Immune Deficiency Syndromes

Volumn 61, Issue 1, 2012, Pages 116-119

  Heffron, Renee ^a   Ngure, Kenneth ^b,c   Mugo, Nelly ^a,b,d   Celum, Connie ^a,e   Kurth, Ann ^a,f   Curran, Kathryn ^a   Baeten, Jared M ^a,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Kenya)

^d KENYATTA NATIONAL HOSPITAL   (Kenya)

^e Kenyatta National Hospital ^*  (United States)

^f NEW YORK UNIVERSITY   (United States)

Author keywords

Africa; antiretrovirals; couples; HIV prevention; pre exposure prophylaxis

Indexed keywords

EMTRICITABINE; TENOFOVIR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KENYA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SERODIAGNOSIS; STATISTICAL ANALYSIS;

ADULT; ANTI-RETROVIRAL AGENTS; CHEMOPREVENTION; CROSS-SECTIONAL STUDIES; DISEASE TRANSMISSION, INFECTIOUS; FAMILY CHARACTERISTICS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KENYA; MALE; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 84865737779     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31825da73f     Document Type: Article

References (15)

1. Baeten JM. New biomedical strategies for HIV-1 prevention in women. Curr Infect Dis Rep. 2008;10:490-498.
2. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med. 2011;365:493-505.
3. Baeten J, Donnell D, Ndase P, et al. ARV PrEP for HIV-1 Prevention among Heterosexual Men and Women. In: 19th Conference on Retroviruses and Opportunistic Infections. Oral abstract #29. Seattle, WA: 2012.
4. Hallett TB, Baeten JM, Heffron R, et al. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med. 2011;8:e1001123.
5. Mujugira A, Baeten JM, Donnell D, et al. Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. PLoS One. 2011;6: e25828.
6. National Center for HIV/AIDS STD and TB Prevention Centers for Disease Control and Prevention. CDC Trial and another major study find prep can reduce risk of hiv infection among heterosexuals. 2011. Available at: http://www.cdc.gov/nchhstp/newsroom/PrEPHeterosexuals.html. Accessed November 25, 2011.
7. University of Washington International Clinical Research Center Partners PrEP Study. Pivotal study finds that HIV medications are highly effective as prophylaxis against HIV infection in men and women in Africa. 2011. Available at: http://depts.washington.edu/uwicrc/research/studies/files/PrEP-PressRelease- UW-13Jul2011.pdf. Accessed November 25, 2011.
8. FHI360. FEM-PrEP June 2011 Update. 2011. Available at: http://www. fhi.org/NR/rdonlyres/erj6hevouwvddigjldvcca6tvtybfolh4nedyfeo4yz2i7 la53jknim6ex42bme2rvyq6zfzovyrkb/FEMPrEPFactSheetJune2011.pdf. Accessed December 15, 2011.
9. Unge C, Johansson A, Zachariah R, et al. Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya. AIDS Care. 2008;20:146-149.
10. Parkes-Ratanshi R, Bufumbo L, Nyanzi-Wakholi B, et al. Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatment. Trop Med Int Health. 2010;15:1347-1356.
11. Katz IT, Essien T, Marinda ET, et al. Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. AIDS. 2011;25: 2177-2181.
12. Micek MA, Gimbel-Sherr K, Baptista AJ, et al. Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr. 2009;52:397-405.
13. Muhamadi L, Nsabagasani X, Tumwesigye MN, et al. Inadequate preantiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD,350 cells/microL) in eastern Uganda. Health Policy. 2010;97:187-194.
14. World Health Organization. Guidance on Couples HIV Testing and Counselling Including Antiretroviral Therapy for Treatment and Prevention in Serodiscordant Couples: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO; 2012.
15. Celum C, Baeten JM. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Curr Opin Infect Dis. 2012;25:51-57.